Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
42,075
+4,564
+12% +$1.56M 2.02% 14
2026
Q1
$13.2M Buy
37,511
+1,749
+5% +$624K 2.12% 14
2025
Q4
$11.7M Buy
35,762
+1,569
+5% +$498K 1.94% 16
2025
Q3
$9.65M Buy
34,193
+2,959
+9% +$858K 1.76% 24
2025
Q2
$8.72M Buy
31,234
+3,329
+12% +$943K 1.79% 23
2025
Q1
$8.69M Buy
27,905
+4,030
+17% +$1.19M 2.14% 19
2024
Q4
$6.22M Buy
23,875
+3,047
+15% +$904K 1.67% 26
2024
Q3
$6.71M Buy
20,828
+2,731
+15% +$893K 1.98% 16
2024
Q2
$5.65M Buy
18,097
+3,893
+27% +$1.14M 1.96% 15
2024
Q1
$4.04M Buy
14,204
+2,856
+25% +$836K 1.6% 21
2023
Q4
$3.27M Buy
11,348
+2,814
+33% +$767K 1.62% 17
2023
Q3
$2.29M Buy
8,534
+2,385
+39% +$595K 1.3% 13
2023
Q2
$1.37M Buy
6,149
+2,215
+56% +$514K 0.83% 26
2023
Q1
$951K Buy
3,934
+2,424
+161% +$595K 0.69% 14
2022
Q4
$397K Buy
+1,510
New +$405K 0.35% 18

Other funds holding AMGN

Kinsale Capital Group's AMGN Position: Q2 2026 in Review

Kinsale Capital Group increased its Amgen (AMGN) stake by 12% in Q2 2026, buying an estimated $1.56M and bringing the position to 42,075 shares worth $15.2M. The position accounts for 2.02% of the portfolio, ranked #14.

Kinsale Capital Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,134 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kinsale Capital Group held 42,075 shares of Amgen worth $15.2M as of Q2 2026.
  • Kinsale Capital Group bought 4,564 Amgen shares in Q2 2026, an estimated $1.56M.
  • Amgen made up 2.02% of Kinsale Capital Group's portfolio in Q2 2026, its #14 holding.
  • Kinsale Capital Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,134 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kinsale Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.